Pharming (PHAR) Long-Term Debt Repayments (2020 - 2023)
Historic Long-Term Debt Repayments for Pharming (PHAR) over the last 6 years, with Q2 2024 value amounting to -$2.1 million.
- Pharming's Long-Term Debt Repayments rose 1856.03% to -$2.1 million in Q2 2024 from the same period last year, while for Jun 2024 it was -$3.9 million, marking a year-over-year decrease of 5077.0%. This contributed to the annual value of -$3217.0 for FY2021, which is 4716.38% down from last year.
- As of Q2 2024, Pharming's Long-Term Debt Repayments stood at -$2.1 million, which was up 1856.03% from -$2.6 million recorded in Q2 2023.
- Pharming's Long-Term Debt Repayments' 5-year high stood at $1.6 million during Q3 2022, with a 5-year trough of -$2.6 million in Q2 2023.
- Over the past 5 years, Pharming's median Long-Term Debt Repayments value was -$797000.0 (recorded in 2022), while the average stood at -$700634.2.
- As far as peak fluctuations go, Pharming's Long-Term Debt Repayments tumbled by 2418918.62% in 2021, and later skyrocketed by 28615.74% in 2022.
- Quarter analysis of 5 years shows Pharming's Long-Term Debt Repayments stood at -$2280.9 in 2020, then crashed by 24189.19% to -$554000.0 in 2021, then crashed by 45.67% to -$807000.0 in 2022, then tumbled by 218.46% to -$2.6 million in 2023, then rose by 18.56% to -$2.1 million in 2024.
- Its Long-Term Debt Repayments stands at -$2.1 million for Q2 2024, versus -$2.6 million for Q2 2023 and -$807000.0 for Q4 2022.